WARNING: We do not support Internet Explorer. It is not secure and will not work correctly. Please come back using a newer web browser.
Find important updates, industry news, and information on CLSI’s upcoming events. Check out past CLSI press releases, upcoming Committees Week, and newsworthy items.
October 7, 2016
To define the current state of reagents and serological assay technology used to measure total human immunoglobulin E (IgE) and IgE antibodies of defined allergen specificities in human blood, the Clinical and Laboratory Standards Institute (CLSI) has published a revised report that focuses on IgE assay design and calibration, validation methods, QA of assay reagents, QC strategies, and clinical applications.
Read MoreSeptember 26, 2014
The Clinical and Laboratory Standards Institute (CLSI) has published an updated standard—Evaluation of Precision of Quantitative Measurement Procedures; Approved Guideline—Third Edition (EP05-A3). This document provides guidance for studies intended to establish the within-site precision performance characteristics of quantitative measurement procedures used in clinical laboratories, and also for studies addressing site-to-site variability.
Read MoreMarch 27, 2012
The Clinical and Laboratory Standards Institute (CLSI) recently published Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria; Approved Standard—Eighth Edition (M11-A8). This standard provides reference methods for the determination of minimal inhibitory concentrations of anaerobic bacteria by agar dilution and broth microdilution.
Read MoreNovember 3, 2011
The Clinical and Laboratory Standards Institute (CLSI) recently published Methods for Antimicrobial Susceptibility Testing for Human Mycoplasmas; Approved Guideline (M43-A). This document provides guidelines for the performance and quality control of agar and broth microdilution antimicrobial susceptibility tests on human mycoplasmas and ureaplasmas.
Read More